Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 66.00
Bid: 65.00
Ask: 67.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.077%)
Open: 66.00
High: 66.00
Low: 66.00
Prev. Close: 66.00
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Patent Case Update

10 Nov 2021 07:00

RNS Number : 8561R
PCI-PAL PLC
10 November 2021
 

 

PCI-PAL PLC

("PCI Pal", "the Company" or "the Group")

Patent Case Update

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, provides an update on the on-going lawsuit filed by its competitor in the UK and US in September 2021.

 

As notified on 16 September 2021, one of PCI Pal's competitors, the US private equity owned, UK company, Semafone Limited, commenced litigation proceedings against the Company in the UK and the US for alleged patent infringement, which relates to one aspect of how one of the Company's products functions. As previously stated, PCI Pal strongly refutes these claims.

 

PCI Pal has this week filed its UK defence and counterclaim to the UK Court in response to the claims, and has summarised two headline points from this filing below:

 

1. PCI Pal does not infringe the patents as claimed by Semafone;

2. The patent is invalid. It lacks novelty and inventive step over the prior art1;

 

PCI Pal believes that the filing shows a strong defence and, in addition to non-infringement, has provided the Court with information on prior art and invalidity arguments. The Court will assess these points and Semafone's arguments and opine accordingly.

 

In the US, PCI Pal has also started the defence of the claims being made.

 

In the last week, PCI Pal has made an application to the US Court for it to invalidate the Semafone US patents under section 101 of the US Patent Act. The Company believes those patents are overly abstract and thus do not qualify for patentable subject matter under the US patent laws. PCI Pal has made this application to ensure it does not spend significant time and resources on further defence points, based around non-infringement and prior art based invalidity, before having the eligibility of the patents reviewed by the US Court. PCI Pal expects to understand the Court's position on this motion in the next few months.

 

PCI Pal is well funded, with no debt, and given the continued strong trading announced today is in a good position to deal with these allegations. The Group will be reporting costs associated with its defence of these allegations as exceptional items in its accounts.

 

PCI Pal is working with its well-established team of advisors to work towards an outcome that it believes will best benefit the Company, whilst at the same time focusing on delivering its strategic growth plans based on the established momentum within the Group.

 

Given the nature of the claims being made against PCI Pal, it is limited in the information it can provide on the case, but the Board will endeavour to keep investors updated as appropriate.

 

 

1Section 2(1) of the Patents Act 1977 Act states that an invention shall be taken to be new if it does not form part of the state of the art. Section 2(2) then goes on to define the state of the art as to be taken to comprise all matter (whether a product, a process, information about either, or anything else) which has at any time before the priority date of the invention been made available to the public (whether in the UK or elsewhere) by written or oral description, by use or in any other way. This is generally known as "prior art".

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

 

 

finnCap (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/Simon Hicks (Corporate Finance)

Richard Chambers (Corporate Broking)

 

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

 

PCIPAL@walbrookpr.com

 

About PCI Pal:

 

PCI Pal is a leading provider of Software-as-a-Service ("SaaS") solutions that empower companies to take payments from their customers securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Our products secure payments and data in any business communications environment including voice, chat, social, email, and contact centre. We are integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers.

 

The entirety of our product-base is available from our global cloud platform hosted in Amazon Web Services ("AWS"), with regional instances across EMEA, North America, and ANZ.

 

For more information visit www.pcipal.com or follow the team on Linkedin: https://www.linkedin.com/company/pci-pal/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXFNEFDFFFA
Date   Source Headline
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims
26th Apr 20227:00 amRNSTrading Update
7th Apr 20227:00 amRNSPDMR share purchase
24th Mar 20227:00 amRNSDirectorate Change
22nd Mar 20227:00 amRNSNew U.S. Patent Approved Covering Cloud IP
15th Mar 20227:00 amRNSStrategic Partnership Driving Open Banking Opps
9th Mar 202211:12 amRNSPDMR/PCA Shareholding
4th Mar 20227:00 amRNSIssue of Options
3rd Mar 20223:50 pmRNSDirector/PDMR Share Purchase
2nd Mar 20224:52 pmRNSPCA/PDMR Shareholding
2nd Mar 202212:05 pmRNSDirector/PDMR Share Purchase
2nd Mar 20228:05 amRNSDirector/PDMR Share Purchases
1st Mar 20227:00 amRNSInterim Results, Analyst Briefing & Investor Pres
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:35 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSTrading Update, Notice of Results & Investor Pres
5th Jan 20227:00 amRNSHolding(s) in Company
10th Dec 20217:00 amRNSIssue of Equity & Total Voting Rights
10th Nov 20214:05 pmRNSResult of AGM
10th Nov 20217:01 amRNSAGM Trading Update
10th Nov 20217:00 amRNSPatent Case Update
18th Oct 20214:15 pmRNSHolding(s) in Company
14th Oct 20217:00 amRNSAnnual Financial Report & Notice of AGM
12th Oct 20217:00 amRNSAmazon Connect and AWS Marketplace availability
16th Sep 20217:00 amRNSUnfounded allegations of patent infringement
18th Aug 20217:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
16th Aug 20217:00 amRNSAppointment of Advisory Committee Members
23rd Jul 20217:30 amRNSHolding(s) in Company
21st Jul 20217:00 amRNSTrading Update
21st Jun 20217:00 amRNSDirector Share Purchase
15th Jun 202110:00 amRNSHolding(s) in Company
8th Jun 20217:00 amRNSTrading Update & Repayment of Debt Facility
25th May 20214:42 pmRNSDirector/PDMR Shareholding
14th May 20215:50 pmRNSHolding(s) in Company
11th May 20217:00 amRNSHolding(s) in Company
10th May 20215:38 pmRNSHolding(s) in Company
10th May 20214:22 pmRNSHolding(s) in Company
10th May 20214:18 pmRNSHolding(s) in Company
10th May 202110:52 amRNSHolding(s) in Company
10th May 20217:00 amRNSIssue of Equity
30th Apr 202112:09 pmRNSResult of Fundraising & Total Voting Rights
30th Apr 20217:00 amRNSProposed Placing to raise £5.5m
20th Apr 20215:38 pmRNSHolding(s) in Company
13th Apr 202110:14 amRNSGrant of Share Options
1st Apr 202111:18 amRNSIssue of Equity
10th Mar 20213:05 pmRNSHolding(s) in Company
8th Mar 20217:00 amRNSInterim Results & Investor Presentation
18th Feb 20217:00 amRNSNotice of Results & Investor Presentation
28th Jan 20217:00 amRNSTrading Update & Notice of Results
20th Jan 20211:02 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.